- Home
- SYRE vs HLF Comparison
SYRE vs HLF Comparison
Compare SYRE & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- HLF
- Stock Information
- Founded
- SYRE 2013
- HLF 1980
- Country
- SYRE United States
- HLF United States
- Employees
- SYRE N/A
- HLF 8600
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- HLF Other Pharmaceuticals
- Sector
- SYRE Health Care
- HLF Health Care
- Exchange
- SYRE Nasdaq
- HLF Nasdaq
- Market Cap
- SYRE 841.4M
- HLF 745.5M
- IPO Year
- SYRE 2016
- HLF N/A
- Fundamental
- Price
- SYRE $14.10
- HLF $6.73
- Analyst Decision
- SYRE Buy
- HLF Strong Buy
- Analyst Count
- SYRE 8
- HLF 4
- Target Price
- SYRE $50.00
- HLF $11.50
- AVG Volume (30 Days)
- SYRE 553.9K
- HLF 2.3M
- Earning Date
- SYRE 05-08-2025
- HLF 04-30-2025
- Dividend Yield
- SYRE N/A
- HLF N/A
- EPS Growth
- SYRE N/A
- HLF 100.43
- EPS
- SYRE N/A
- HLF 2.74
- Revenue
- SYRE N/A
- HLF $4,950,500,000.00
- Revenue This Year
- SYRE N/A
- HLF N/A
- Revenue Next Year
- SYRE N/A
- HLF $3.95
- P/E Ratio
- SYRE N/A
- HLF $2.51
- Revenue Growth
- SYRE N/A
- HLF N/A
- 52 Week Low
- SYRE $10.91
- HLF $5.04
- 52 Week High
- SYRE $40.49
- HLF $12.79
- Technical
- Relative Strength Index (RSI)
- SYRE 48.32
- HLF 44.66
- Support Level
- SYRE $12.29
- HLF $6.59
- Resistance Level
- SYRE $15.77
- HLF $7.53
- Average True Range (ATR)
- SYRE 1.06
- HLF 0.48
- MACD
- SYRE 0.08
- HLF 0.04
- Stochastic Oscillator
- SYRE 52.08
- HLF 25.46
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.